About
Dr. Kwon serves as Venture Partner at GT Healthcare Capital Partners. Most recently, Dr. Kwon served as Director, Head of Corporate Development and Transactions at Genexine, a Korean clinical stage biotechnology company focused on the development and commercialization of innovative immunotherapeutics and next generation novel long-acting biologics. Before joining Genexine, Dr. Kown was Vice President, Chief Strategy Officer at TheragenEtex, a genomics company developing innovative diagnosis tools and new drugs using the genomics and bioinformatics technologies. Before joining TheragenEtex, Dr. Kwon was a research analyst at Daewoo Security, covering the biotechnology and pharmaceutical sector. Dr. Kwon started in industry as Manager, Business Development at Oscotec, a bone specialized biotechnology company in Korea. Dr. Kwon received his Doctor of Philosophy degree in Biopharmaceutical Engineering, Master of Science in Life Science, Bachelor of Science in Genetic Engineering, all
Position in the VCSift Database
- • 4 investors at GT Healthcare Capital Partners are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Jai Hyun Kwon is one of them.
- • 150 investors are based in South Korea.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- South Korea
Contact Information
Find more investors like Jai Hyun
Search Investors